Table 2.
Sexual and drug-use behaviours of men who have sex with men, men who have sex with women and women who have sex with men with HIV diagnosis for at least 12 months receiving medical care in the United States, Medical Monitoring Project, 2009.
| Characteristicsa | Totalb (n = 4094) | MSM (n = 1897) | MSW (n = 1016) | WSM (n = 1093) | P for modified Rao-Scott chi-square test |
| Weighted % (95% CI) | Weighted % (95% CI) | Weighted % (95% CI) | Weighted % (95% CI) | ||
| Number of sex partners | |||||
| None | 38 (35–40) | 31 (28–34) | 43 (38–47) | 46 (43–48) | <0.001 |
| 1 | 38 (36–41) | 31 (28–33) | 44 (41–48) | 47 (44–50) | |
| ≥ 2 | 24 (21–27) | 39 (34–42) | 13 (11–15) | 8 (5–10) | |
| Self-reported sexually transmitted infection | |||||
| Yes | 13 (11–15) | 16 (13–19) | 6 (5–8) | 12 (8–16) | <0.001 |
| No | 31 (29–33) | 32 (29–34) | 26 (23–30) | 35 (31–39) | |
| Not tested | 56 (54–58) | 52 (49–56) | 68 (64–72) | 53 (49–57) | |
| Used noninjection drugs | 27 (26–29) | 35 (32–37) | 24 (21–27) | 17 (15–19) | <0.001 |
| Drank alcohol before/during sex | 24 (22–26) | 32 (29–35) | 19 (16–32) | 15 (13–18) | <0.001 |
| Drug use before or during sex | |||||
| Any drug | 11 (10–13) | 16 (14–18) | 7 (5–9) | 7 (5–8) | <0.001 |
| Stimulants | 5 (4–6) | 7 (6–9) | 2 (1–3) | 3 (2–4) | <0.001 |
| Poppers | 3 (2–4) | 6 (4–7) | — | — | |
| Methamphetamines | 2 (2–3) | 5 (3–6) | — | — | |
| Exchanged sex for money/goods | 4 (3–4) | 3 (2–4) | 5 (3–7) | 2 (1–3) | 0.009 |
CI, confidence interval; MSM, men who have sex with men; MSW, men who have sex with women; WSM, women who have sex with men; dash, coefficient of variation was >0.30 (sample size too small to produce valid estimates).
aRefers to the 12 months before interview (June 2008–May 2009)
bExcludes persons who reported no sexual behaviour and did not report their sexual orientation as heterosexual, homosexual or bisexual. Includes transgender participants (n = 64) and women who have sex with women (n = 26) because sample sizes were too small to provide valid estimates for separate analysis.